跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REPATHA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
REPATHA
Authorized
STANDARD
REPATHA
Amgen Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
826a1bf2fa2fa40a
Company
Amgen Canada Inc
Type
Standard
Approval Details
Approval Id
826a1bf2fa2fa40a
Drug Approval Canada Name
REPATHA
Product Name
REPATHA
Status
Marketed
Status Date
2017-04-04
Original Market Date
2017-04-04
Din
02459779
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Schedule D , Prescription
Ahfs
24:06.24
Atc Original
C10AX13 EVOLOCUMAB
Atc Name
c 10 ax 13
Aig Number
0157370002
Company Name
Amgen Canada Inc
Company Address
300, 6775 Financial Drive, Mississauga, Ontario, Canada, L5N 0A4
Active Ingredients
EVOLOCUMAB
120 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
826a1bf2fa2fa40a
Type
Standard
Back to Health Canada Approvals